As of 2025-07-10, the Fair Value of Rock Creek Pharmaceuticals Inc (RCPIQ) is -0.35 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.00 USD, the upside of Rock Creek Pharmaceuticals Inc is -350,270.21%.
With the market price of 0.00 USD and our fair value calculation, Rock Creek Pharmaceuticals Inc (RCPIQ) is not a good investment. Investing in RCPIQ stocks now will result in a potential loss of 350,270.21%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2011-12-31 | 2012-12-31 | 2013-12-31 | 2014-12-31 | 2015-12-31 | 5Y Avg | |
| Net income | -37.99 | -22.85 | -32.83 | -38.52 | -6.84 | -27.81 |
| YoY growth | -34.32% | 39.84% | -43.67% | -17.31% | 82.23% | 5.35% |
| Market Cap (mil) | 0.02 |
| P/E | |
| Forward P/E |
| EPS | -0.07 |
| Avg earnings growth rate | 5.35% |
| TTM earnings | -11.15 |